Autopsy report · NCT03939858
Bioenergetic Profiling and Cognition in GBM Patients
Cause of deathFunding or business
“Funding and laboratory access issues, study is closed”
Life of this trial
- Registered 6 months before it started.
- Ran for about 3 years 8 months before it stopped.
- 6 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- Wake Forest University Health Sciences
- Sponsor type
- University, hospital or other
- Conditions
- Glioblastoma
- Interventions
- Cognitive Assessment; Blood Collection; Bioenergetic Profiling
- Participants
- 6
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia
“The study was closed due to the end of funding.” - Autoantibodies in Breast Cancer Detection
“Study closed to enrollment and data and specimen collection due to lack of funding.” - Changes in Bone Turnover With Increased Incretin Hormone Exposure
“Study closed by sponsor. Funding ended.” - A Phase 1, Open-Label Study of Intravenous Sildenafil in Patients With Cirrhosis
“The study is closed due to lack of funding to support the study.” - Team Based Equity Conscious Telemedicine Approach to Hypertension
“closed because we were funded for another similar study”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.